Novel targeted agents for the treatment of lung cancer in China

Cancer
Si-Yang LiuYi-Long Wu

Abstract

Since the discovery of epidermal growth factor receptor mutations and epidermal growth factor receptor tyrosine kinase inhibitors, lung cancer treatment in China has entered the precision era. However, novel targeted agents based on novel biomarkers still need to be developed. In the current study, the authors review the biomarker features of lung cancer in the Chinese population and the novel agents that are aimed at novel targets. Furthermore, they discuss issues that require improvement for the production of novel drugs and provided future directions for development in China.

References

Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckChristian Manegold
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Mar 25, 2011·Science Translational Medicine·Lecia V SequistJeffrey A Engelman
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Feb 9, 2012·Expert Opinion on Therapeutic Targets·Yi-long Wu, Qing Zhou
Mar 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ji-Youn HanJin Soo Lee
Apr 18, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Su-Jung KimYung-Jue Bang
Oct 20, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jin-Ji YangYi-Long Wu
Nov 28, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hye Ryun KimByoung Chul Cho
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Aug 7, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jin LiHao Yu
Mar 19, 2014·Drug Discovery Today·Xingwang Zhang, Wei Wu
Mar 29, 2014·The New England Journal of Medicine·Alice T ShawJeffrey A Engelman
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn
Jun 4, 2014·International Journal of Oncology·Antonio RossiCesare Gridelli
Jun 12, 2014·Drugs·Raewyn M Poole, Asha Vaidya
Jun 26, 2014·The New England Journal of Medicine·Alice T Shaw, Jeffrey A Engelman
Aug 27, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yen-Fu ChenPan-Chyr Yang
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Ambedkar Raj Kulandai VeluIlavarasi Sinduja
Sep 30, 2014·The New England Journal of Medicine·Alice T ShawA John Iafrate
Oct 11, 2014·World Journal of Clinical Oncology·Kim-Son H NguyenHeather Wakelee
Oct 25, 2014·Therapeutic Advances in Medical Oncology·Thomas E Stinchcombe
Dec 3, 2014·Drug Discovery Today·Yi-Long WuYumei Yang
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators
Dec 24, 2014·Expert Opinion on Therapeutic Targets·Anna LiYi-Long Wu
Dec 24, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silvia NovelloUNKNOWN LUME-Lung 1 Study Group
Jan 21, 2015·Current Opinion in Oncology·Niels ReinmuthMartin Reck
Feb 12, 2014·Lung Cancer : Targets and Therapy·Lan-Ying Gou, Yi-Long Wu

❮ Previous
Next ❯

Citations

Oct 7, 2015·Biomarkers in Medicine·Manolo D'ArcangeloAlastair Greystoke
Sep 4, 2015·Cancer·Suresh S Ramalingam, Fadlo R Khuri
Jun 4, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Si-Yang LiuYi-Long Wu
Nov 3, 2015·Genomics & Informatics·Seon-Kyu Kim, In-Sun Chu
Jul 7, 2017·Journal of Hematology & Oncology·Si-Yang Liu, Yi-Long Wu
Feb 2, 2021·Journal of Cellular and Molecular Medicine·Ying LuZengguang Xu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.